Women using an intrauterine device are not at increased risk for acquisition or persistence of human papillomavirus (HPV) infection, a recent study found, and device use is safe among women with HPV infections and at risk for HPV acquisitions. This according to a cohort study of 676 sexually active young women from October 2000 to June 2014 that evaluated the association between intrauterine device use and cervical high-risk HPV acquisition and clearance. Researchers found:
- 85 women used an intrauterine device at some time during follow-up.
- Among 14,513 study visits, women reported intrauterine device use at 505 visits.
- After adjusting for behavioral confounders, there was no association observed between intrauterine device use and/or HPV acquisition (HR, 0.50) or clearance of HPV infection (HR, 1.44).
Averbach SH, Ma Y, Smith-Mccune K, Shiboski S, Moscicki AB. The effect of intrauterine devices on acquisition and clearance of human papillomavirus. [Published online ahead of print December 13, 2016]. Am J Obstet Gynecol. doi:10.1016/j.ajog.2016.11.1053.
This Week's Must Reads
Must Reads in Contraception
Bleeding and Spotting with the LNG 13.5 mg IUS, Contraception; ePub 2019 Mar 1; Shimoni, et al
Contraception and Chronic Opioid Prescriptions, Contraception; ePub 2019 Feb 11; Ray-Griffith, et al
Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al
Contraceptive Switching & Discontinuation, Am J Obstet Gynecol; ePub 2018 Dec 18; Simmons, et al
Efficacy of a Levonorgestrel 52-mg IU System, Obstet Gynecol; ePub 2018 Dec 4; Teal, et al